Suppr超能文献

关于大麻用于治疗常见国家批准的医学和精神疾病的安全性和有效性的叙述性综述。

Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.

作者信息

Belendiuk Katherine A, Baldini Lisa L, Bonn-Miller Marcel O

机构信息

Institute of Human Development, University of California, 1121 Tolman Hall #1690, Berkeley, CA, 94720, USA.

Palo Alto University, 1791 Arastradero Road, Palo Alto, CA, 94304, USA.

出版信息

Addict Sci Clin Pract. 2015 Apr 21;10:10. doi: 10.1186/s13722-015-0032-7.

Abstract

The present investigation aimed to provide an objective narrative review of the existing literature pertaining to the benefits and harms of marijuana use for the treatment of the most common medical and psychological conditions for which it has been allowed at the state level. Common medical conditions for which marijuana is allowed (i.e., those conditions shared by at least 80 percent of medical marijuana states) were identified as: Alzheimer's disease, amyotrophic lateral sclerosis, cachexia/wasting syndrome, cancer, Crohn's disease, epilepsy and seizures, glaucoma, hepatitis C virus, human immunodeficiency virus/acquired immunodeficiency syndrome, multiple sclerosis and muscle spasticity, severe and chronic pain, and severe nausea. Post-traumatic stress disorder was also included in the review, as it is the sole psychological disorder for which medical marijuana has been allowed. Studies for this narrative review were included based on a literature search in PsycINFO, MEDLINE, and Google Scholar. Findings indicate that, for the majority of these conditions, there is insufficient evidence to support the recommendation of medical marijuana at this time. A significant amount of rigorous research is needed to definitively ascertain the potential implications of marijuana for these conditions. It is important for such work to not only examine the effects of smoked marijuana preparations, but also to compare its safety, tolerability, and efficacy in relation to existing pharmacological treatments.

摘要

本调查旨在对现有文献进行客观的叙述性综述,这些文献涉及在州一级允许使用大麻治疗最常见的医学和心理疾病的益处和危害。大麻被允许用于治疗的常见医学疾病(即至少80%的医用大麻州都认可的疾病)包括:阿尔茨海默病、肌萎缩侧索硬化症、恶病质/消瘦综合征、癌症、克罗恩病、癫痫和发作、青光眼、丙型肝炎病毒、人类免疫缺陷病毒/获得性免疫缺陷综合征、多发性硬化症和肌肉痉挛、严重慢性疼痛以及严重恶心。创伤后应激障碍也被纳入综述,因为它是唯一一种允许使用医用大麻治疗的心理疾病。本次叙述性综述的研究是基于在PsycINFO、MEDLINE和谷歌学术上的文献检索而纳入的。研究结果表明,对于这些疾病中的大多数,目前没有足够的证据支持推荐使用医用大麻。需要进行大量严格的研究来明确确定大麻对这些疾病的潜在影响。此类研究不仅要考察吸食大麻制剂的效果,还应比较其与现有药物治疗相比的安全性、耐受性和疗效,这一点很重要。

相似文献

3
Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.
Ann Pharmacother. 2020 Nov;54(11):1109-1143. doi: 10.1177/1060028020930189. Epub 2020 Jun 2.
4
Medical use of cannabis products: Lessons to be learned from Israel and Canada.
Schmerz. 2016 Feb;30(1):3-13. doi: 10.1007/s00482-015-0083-4.
5
Medical marijuana: Showdown at the cannabis corral.
Nature. 2015 Sep 24;525(7570):S15-7. doi: 10.1038/525S15a.
6
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.
Am J Drug Alcohol Abuse. 2014 Jan;40(1):23-30. doi: 10.3109/00952990.2013.821477. Epub 2013 Nov 8.
9
Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
Depress Anxiety. 2017 Nov;34(11):1006-1017. doi: 10.1002/da.22664. Epub 2017 Jun 21.
10
Medical marijuana: legal considerations.
STEP Perspect. 1999 Summer;99(2):5.

引用本文的文献

1
Blinded by the Mind: Exploring the Hidden Psychiatric Burden in Glaucoma Patients.
Biomedicines. 2025 Jan 7;13(1):116. doi: 10.3390/biomedicines13010116.
3
"We want what's best for patients." nurse leaders' attitudes about medical cannabis: A qualitative study.
Int J Nurs Stud Adv. 2022 Jan 30;4:100065. doi: 10.1016/j.ijnsa.2022.100065. eCollection 2022 Dec.
4
Pharmacokinetics of delta-9-tetrahydrocannabinol following acute cannabis smoke exposure in mice; effects of sex, age, and strain.
Front Pharmacol. 2023 Aug 28;14:1227220. doi: 10.3389/fphar.2023.1227220. eCollection 2023.
5
Biosynthesis of Phytocannabinoids and Structural Insights: A Review.
Metabolites. 2023 Mar 17;13(3):442. doi: 10.3390/metabo13030442.
6
Examining the role of cannabinoids on osteoporosis: a review.
Arch Osteoporos. 2022 Nov 19;17(1):146. doi: 10.1007/s11657-022-01190-x.
7
A bibliometric analysis of the cannabis and cannabinoid research literature.
J Cannabis Res. 2022 May 25;4(1):25. doi: 10.1186/s42238-022-00133-0.
8
Slovenian Pet Owners' Experience, Attitudes, and Predictors Regarding Cannabinoid Use in Dogs and Cats.
Front Vet Sci. 2022 Jan 5;8:796673. doi: 10.3389/fvets.2021.796673. eCollection 2021.
9
Green Hope: Perspectives on Cannabis from People who Use Opioids.
Sociol Inq. 2021 Aug;91(3):668-695. doi: 10.1111/soin.12359. Epub 2020 Feb 13.
10
Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada.
Can J Psychiatry. 2022 Jun;67(6):470-480. doi: 10.1177/07067437211043393. Epub 2021 Sep 14.

本文引用的文献

3
Adverse health effects of marijuana use.
N Engl J Med. 2014 Jun 5;370(23):2219-27. doi: 10.1056/NEJMra1402309.
4
Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders.
Int Rev Psychiatry. 2014 Apr;26(2):237-47. doi: 10.3109/09540261.2014.901300.
5
Effects of cannabis on cognition in patients with MS: a psychometric and MRI study.
Neurology. 2014 May 27;82(21):1879-87. doi: 10.1212/WNL.0000000000000446. Epub 2014 Apr 30.
7
Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.
Front Pharmacol. 2014 Mar 5;5:37. doi: 10.3389/fphar.2014.00037. eCollection 2014.
8
Cannabinoids for epilepsy.
Cochrane Database Syst Rev. 2014 Mar 5;2014(3):CD009270. doi: 10.1002/14651858.CD009270.pub3.
10
Cannabinoid hyperemesis syndrome.
Hosp Pharm. 2013 Sep;48(8):650-5. doi: 10.1310/hpj4808-650.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验